UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$3.29B |
| 2 |
NVIDIA
NVDA
|
$2.75B |
| 3 |
Microsoft
MSFT
|
$2.26B |
| 4 |
Amazon
AMZN
|
$1.79B |
| 5 |
UnitedHealth
UNH
|
$1.16B |
Top Sells
| 1 |
Pinduoduo
PDD
|
$1.19B |
| 2 |
Amphenol
APH
|
$415M |
| 3 |
Iron Mountain
IRM
|
$288M |
| 4 |
HDFC Bank
HDB
|
$211M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$202M |
Sector Composition
| 1 | Technology | 34.77% |
| 2 | Financials | 12.98% |
| 3 | Consumer Discretionary | 11.47% |
| 4 | Healthcare | 10.94% |
| 5 | Communication Services | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Keros Therapeutics
KROS
$633M
| $1.02M | ﹤0.01% |
64,416
+13,864
| +27% | +$219K |
|
2327
York Water
YORW
$447M
| $1.02M | ﹤0.01% |
31,120
+7,576
| +32% | +$248K |
|
2328
Sapiens International
SPNS
$2.4B
| $1.02M | ﹤0.01% |
37,851
+3,016
| +9% | +$81K |
|
2329
Central Garden & Pet
CENT
$2.37B
| $1.02M | ﹤0.01% |
26,209
-444
| -2% | -$17.2K |
|
|
RDUS
2330
DELISTED
Radius Recycling
RDUS
| $1.01M | ﹤0.01% |
66,480
+3,090
| +5% | +$47K |
|
2331
Myers Industries
MYE
$611M
| $1.01M | ﹤0.01% |
91,545
+12,567
| +16% | +$139K |
|
2332
MediaAlpha
MAX
$699M
| $1.01M | ﹤0.01% |
89,478
+16,050
| +22% | +$181K |
|
2333
Pacific Biosciences
PACB
$381M
| $1.01M | ﹤0.01% |
551,904
+38,103
| +7% | +$69.7K |
|
2334
iRadimed
IRMD
$916M
| $1.01M | ﹤0.01% |
18,359
+8,774
| +92% | +$483K |
|
|
GOOD
2335
Gladstone Commercial Corp
GOOD
$616M
| $1.01M | ﹤0.01% |
62,097
+16,422
| +36% | +$267K |
|
2336
TORM
TRMD
$2.25B
| $1.01M | ﹤0.01% |
51,782
| – | – |
|
|
EFXT
2337
Enerflex
EFXT
$1.22B
| $1M | ﹤0.01% |
100,995
-517
| -0.5% | -$5.14K |
|
|
GMRE
2338
Global Medical REIT
GMRE
$508M
| $1M | ﹤0.01% |
129,965
+9,351
| +8% | +$72.2K |
|
|
TUYA
2339
Tuya Inc
TUYA
$1.53B
| $1M | ﹤0.01% |
560,101
+209,985
| +60% | +$376K |
|
2340
EVgo
EVGO
$529M
| $1M | ﹤0.01% |
+247,215
| New | +$1M |
|
2341
Heartland Express
HTLD
$666M
| $991K | ﹤0.01% |
88,280
+12,021
| +16% | +$135K |
|
2342
Universal Insurance Holdings
UVE
$697M
| $989K | ﹤0.01% |
46,959
-4,055
| -8% | -$85.4K |
|
2343
Enliven Therapeutics
ELVN
$1.19B
| $984K | ﹤0.01% |
43,714
+17,546
| +67% | +$395K |
|
2344
Target Hospitality
TH
$876M
| $977K | ﹤0.01% |
101,089
+22,355
| +28% | +$216K |
|
2345
Scholastic
SCHL
$654M
| $974K | ﹤0.01% |
45,646
+9,293
| +26% | +$198K |
|
2346
Standard BioTools
LAB
$497M
| $970K | ﹤0.01% |
554,203
+247,332
| +81% | +$433K |
|
|
BBUC
2347
Brookfield Business Corp
BBUC
$2.37B
| $968K | ﹤0.01% |
39,918
| – | – |
|
2348
Claros Mortgage Trust
CMTG
$538M
| $961K | ﹤0.01% |
212,681
-14,082
| -6% | -$63.7K |
|
2349
Atlas Energy Solutions
AESI
$1.34B
| $961K | ﹤0.01% |
43,339
-1,592
| -4% | -$35.3K |
|
2350
Relay Therapeutics
RLAY
$710M
| $958K | ﹤0.01% |
232,582
+9,293
| +4% | +$38.3K |
|